Our Press Releases | Association for Accessible Medicines

New White Paper - Read AAM Report on Drug Shortages

AAM Report: Middlemen Block Patient Access to New Generics

Jan 23, 2023 | Susan Reilly

Study Finds Middlemen Increasingly Block Patient Access to New Generics

Capitol Building - Washington D.C.

Dec 20, 2022 | Susan Reilly

AAM Statement on the Consolidated Appropriations Act of 2023

Dec 13, 2022 | Susan Reilly

AAM Statement on CMS's Proposed Rule Requiring Generic Drugs to be Covered on Generic Tiers

IGBA Global Biosimilars Week: Strengthening Healthcare – The Value of Biosimilar Medicines. November 11-18, 2022.

Nov 14, 2022 | Susan Reilly

Raising Awareness for Biosimilars for Stakeholders Around the World

Closeup cashless wireless payment with credit card at the pharmacy

Oct 14, 2022 | Susan Reilly

AAM Statement on President Biden's Executive Order on Lowering Prescription Drug Costs

Oct 3, 2022 | Susan Reilly

AAM Statement on the Centers for Medicare & Medicaid Services’ Implementation of Medicare Part B Payment Changes for Biosimilars

2022 2022 U.S Generic and Biosimilar Medicines Savings Report

Sep 21, 2022 | Susan Reilly

Generic and Biosimilar Drugs Generate A Record $373 Billion For America’s Patients and Healthcare System in 2021

Avalere: New Analysis of Trends in Part D Generic Tiering, Pricing, and Patient Spending

Sep 15, 2022 | Susan Reilly

AAM Statement: New Study Shows Formulary Abuses Force Patients to Pay More for Generic Drugs Even as the Prices of Those Drugs Go Down

Capitol Building - Washington D.C.

Aug 7, 2022 | Allen Goldberg

AAM Statement on Senate Passage of Inflation Reduction Act

David Gaugh at GRx+Biosims (North Bethesda, Maryland)

Jul 28, 2022 | Allen Goldberg

Association for Accessible Medicines (AAM) Elevates David Gaugh to Executive Vice President for Sciences & Regulatory Affairs

Misguided Drug Pricing Reform

Jul 6, 2022 | Allen Goldberg

AAM Statement on BBB 2.0

Drug manufacture

Jun 6, 2022 | Allen Goldberg

Giuseppe Randazzo Joins AAM as Vice President, Sciences and Regulatory Affairs